At CEDAR, Eugene Tu works on identifying and developing enabling technologies for biomarker discovery and diagnostics. He was on the founding team of several biotech startups [Nanogen, IPO; Genoptix, IPO; Omniome, acquired; Veriskin, wip] and drove technology development and team building in highly collaborative fast learn environments. Gene is an expert in next-gen DNA and protein sequencing, diagnostics, product development, and IP.